<!DOCTYPE html PUBLIC "-//W3C//DTD XHTML 1.0 Transitional//EN" "http://www.w3.org/TR/xhtml1/DTD/xhtml1-transitional.dtd">
<html xmlns="http://www.w3.org/1999/xhtml">
<head>
  <meta http-equiv="Content-Type" content="text/html; charset=utf-8" />
  <meta http-equiv="Content-Style-Type" content="text/css" />
  <meta name="generator" content="pandoc" />
  <title></title>
  <style type="text/css">code{white-space: pre;}</style>
</head>
<body>
<h3 id="mondo0017719"><a href="http://purl.obolibrary.org/obo/MONDO_0017719">MONDO:0017719</a></h3>
<p><strong>Label:</strong> gangliosidosis</p>
<p><strong>Subclasses:</strong> <a href="http://purl.obolibrary.org/obo/MONDO_0017720">MONDO:0017720</a> (GM2 gangliosidosis), <a href="http://purl.obolibrary.org/obo/MONDO_0018149">MONDO:0018149</a> (GM1 gangliosidosis), <a href="http://purl.obolibrary.org/obo/MONDO_0010100">MONDO:0010100</a> (Tay-Sachs disease), <a href="http://purl.obolibrary.org/obo/MONDO_0010006">MONDO:0010006</a> (Sandhoff disease), <a href="http://purl.obolibrary.org/obo/MONDO_0002609">MONDO:0002609</a> (gangliosidosis GM1),</p>
<p><strong>Corr. equiv. classes:</strong> <a href="http://purl.obolibrary.org/obo/OMIM_272800">OMIM:272800</a>, <a href="http://purl.obolibrary.org/obo/OMIM_230650">OMIM:230650</a>, <a href="http://www.orpha.net/ORDO/Orphanet_354">Orphanet:354</a>, <a href="http://www.orpha.net/ORDO/Orphanet_309162">Orphanet:309162</a>, <a href="http://purl.obolibrary.org/obo/OMIM_230600">OMIM:230600</a>, <a href="http://purl.obolibrary.org/obo/OMIM_230500">OMIM:230500</a>, <a href="http://www.orpha.net/ORDO/Orphanet_309152">Orphanet:309152</a>, <a href="http://www.orpha.net/ORDO/Orphanet_309155">Orphanet:309155</a>, <a href="http://www.orpha.net/ORDO/Orphanet_845">Orphanet:845</a>, <a href="http://purl.obolibrary.org/obo/OMIM_268800">OMIM:268800</a>, <a href="http://www.orpha.net/ORDO/Orphanet_796">Orphanet:796</a>, <a href="http://www.orpha.net/ORDO/Orphanet_309169">Orphanet:309169</a>,</p>
<p><strong>Class expressions from DL-Learner:</strong></p>
<ul>
<li><a href="http://purl.obolibrary.org/obo/HP_0010729">HP:0010729</a> (Cherry red spot of the macula) and (not (<a href="http://purl.obolibrary.org/obo/HP_0011849">HP:0011849</a> (Abnormal bone ossification))) 71.29%</li>
<li><a href="http://purl.obolibrary.org/obo/HP_0010729">HP:0010729</a> (Cherry red spot of the macula) and (not (<a href="http://purl.obolibrary.org/obo/HP_0005561">HP:0005561</a> (Abnormality of bone marrow cell morphology))) 71.29%</li>
<li><a href="http://purl.obolibrary.org/obo/HP_0010729">HP:0010729</a> (Cherry red spot of the macula) and (not (<a href="http://purl.obolibrary.org/obo/HP_0012144">HP:0012144</a> (Abnormality of cells of the monocyte/macrophage lineage))) 68.30%</li>
<li><a href="http://purl.obolibrary.org/obo/HP_0010729">HP:0010729</a> (Cherry red spot of the macula) and (not (<a href="http://purl.obolibrary.org/obo/HP_0012067">HP:0012067</a> (Glycopeptiduria))) 68.30%</li>
<li><a href="http://purl.obolibrary.org/obo/HP_0010729">HP:0010729</a> (Cherry red spot of the macula) and (not (<a href="http://purl.obolibrary.org/obo/HP_0012061">HP:0012061</a> (Urinary excretion of sialylated oligosaccharides))) 68.30%</li>
<li><a href="http://purl.obolibrary.org/obo/HP_0010729">HP:0010729</a> (Cherry red spot of the macula) and (not (<a href="http://purl.obolibrary.org/obo/HP_0011843">HP:0011843</a> (Abnormality of skeletal physiology))) 68.30%</li>
<li><a href="http://purl.obolibrary.org/obo/HP_0010729">HP:0010729</a> (Cherry red spot of the macula) and (not (<a href="http://purl.obolibrary.org/obo/HP_0010974">HP:0010974</a> (Abnormality of myeloid leukocytes))) 68.30%</li>
<li><a href="http://purl.obolibrary.org/obo/HP_0010729">HP:0010729</a> (Cherry red spot of the macula) and (not (<a href="http://purl.obolibrary.org/obo/HP_0010766">HP:0010766</a> (Ectopic calcification))) 68.30%</li>
<li><a href="http://purl.obolibrary.org/obo/HP_0010729">HP:0010729</a> (Cherry red spot of the macula) and (not (<a href="http://purl.obolibrary.org/obo/HP_0010471">HP:0010471</a> (Oligosacchariduria))) 68.30%</li>
<li><a href="http://purl.obolibrary.org/obo/HP_0010729">HP:0010729</a> (Cherry red spot of the macula) and (not (<a href="http://purl.obolibrary.org/obo/HP_0004349">HP:0004349</a> (Reduced bone mineral density))) 68.30%</li>
<li><a href="http://purl.obolibrary.org/obo/HP_0010729">HP:0010729</a> (Cherry red spot of the macula) and (not (<a href="http://purl.obolibrary.org/obo/HP_0004348">HP:0004348</a> (Abnormality of bone mineral density))) 68.30%</li>
<li><a href="http://purl.obolibrary.org/obo/HP_0010729">HP:0010729</a> (Cherry red spot of the macula) and (not (<a href="http://purl.obolibrary.org/obo/HP_0004333">HP:0004333</a> (Bone-marrow foam cells))) 68.30%</li>
<li><a href="http://purl.obolibrary.org/obo/HP_0010729">HP:0010729</a> (Cherry red spot of the macula) and (not (<a href="http://purl.obolibrary.org/obo/HP_0004311">HP:0004311</a> (Abnormality of macrophages))) 68.30%</li>
<li><a href="http://purl.obolibrary.org/obo/HP_0010729">HP:0010729</a> (Cherry red spot of the macula) and (not (<a href="http://purl.obolibrary.org/obo/HP_0003461">HP:0003461</a> (Increased urinary O-linked sialopeptides))) 68.30%</li>
<li><a href="http://purl.obolibrary.org/obo/HP_0010729">HP:0010729</a> (Cherry red spot of the macula) and (not (<a href="http://purl.obolibrary.org/obo/HP_0000943">HP:0000943</a> (Dysostosis multiplex))) 68.30%</li>
</ul>
</body>
</html>
